A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide

Details for Australian Patent Application No. 2004295152 (hide)

Owner AstraZeneca AB

Inventors Bosson, Bo Lars Gustaf; Zistler, Andrea; Zaramella, Simone; Blixt, Hans Jorgen; Gatti, Roberto Guiseppe Paolo; Senior, Michael William; Vogtli, Kurt

Agent Davies Collison Cave

Pub. Number AU-B-2004295152

PCT Pub. Number WO2005/054168

Priority 0303220-8 28.11.03 SE

Filing date 25 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 2 July 2009

International Classifications

C07C 51/487 (2006.01) Preparation of carboxylic acids or their salts, halides, or anhydrides

C07C 59/64 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 231/20 (2006.01) Preparation of carboxylic acid amides

C07C 237/24 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054168 Priority application(s): WO2005/054168

18 June 2009 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from: Gatti, Roberto Giuseppe Paolo to: Gatti, Roberto Guiseppe Paolo 2006

2 July 2009 Application Accepted

  Published as AU-B-2004295152

29 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295154-1-alkyl-3-thio-substituted indole2-alkynoic acids useful for the treatment for Alzheimer's disease and related conditions

2004295148-Developments in biologically active methylene blue derivatives (2)